These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Need and prospects for prevention of cardiac failure. Kannel WB Eur J Clin Pharmacol; 1996; 49 Suppl 1():S3-9. PubMed ID: 8834926 [TBL] [Abstract][Full Text] [Related]
4. Some lessons in cardiovascular epidemiology from Framingham. Kannel WB Am J Cardiol; 1976 Feb; 37(2):269-82. PubMed ID: 1246956 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and risk profile of cardiac failure. Kannel WB; Cupples A Cardiovasc Drugs Ther; 1988 Nov; 2 Suppl 1():387-95. PubMed ID: 3154646 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and risk profile of cardiac failure. Kannel WB; Cupples A Cardiovasc Drugs Ther; 1988 Nov; 2(Suppl 1):387-395. PubMed ID: 27722843 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol and atherosclerosis: a contemporary perspective. Kashyap ML Ann Acad Med Singap; 1997 Jul; 26(4):517-23. PubMed ID: 9395824 [TBL] [Abstract][Full Text] [Related]
8. An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study. Kannel WB; McGee DL; Schatzkin A Drugs; 1984 Oct; 28 Suppl 1():1-16. PubMed ID: 6499693 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. Kannel WB J Cardiovasc Risk; 1994 Dec; 1(4):333-9. PubMed ID: 7621317 [TBL] [Abstract][Full Text] [Related]
11. Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women. Kannel WB; Vokonas PS Ann Epidemiol; 1992; 2(1-2):5-14. PubMed ID: 1342264 [TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular risk factors and prevention in women: similarities and differences]. Sclavo M Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880 [TBL] [Abstract][Full Text] [Related]
13. Sudden coronary death in women. Kannel WB; Wilson PW; D'Agostino RB; Cobb J Am Heart J; 1998 Aug; 136(2):205-12. PubMed ID: 9704680 [TBL] [Abstract][Full Text] [Related]
14. Sudden death: lessons from subsets in population studies. Kannel WB; Schatzkin A J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):141B-149B. PubMed ID: 3889106 [TBL] [Abstract][Full Text] [Related]
15. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910 [TBL] [Abstract][Full Text] [Related]
17. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis]. Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811 [TBL] [Abstract][Full Text] [Related]
18. Update on fibrinogen as a cardiovascular risk factor. Kannel WB; D'Agostino RB; Belanger AJ Ann Epidemiol; 1992 Jul; 2(4):457-66. PubMed ID: 1342296 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of sudden coronary death: population at risk. Kannel WB; Gagnon DR; Cupples LA Can J Cardiol; 1990 Dec; 6(10):439-44. PubMed ID: 2148709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]